Structural characterization of four genetic variants of human serum albumin associated with alloalbuminemia in Italy.

A long-term electrophoretic survey on plasma proteins, which was carried out in several clinical laboratories in Italy, identified 28 different genetic variants of human serum albumin and four cases of analbuminemia. We have previously characterized 16 point mutations, 3 C-terminal mutants, and the genetic defects in two analbuminemic subjects. Here, we report the molecular defects of four alloalbumins that have been characterized by protein structural analysis. Of these, three represent new single-point mutations: albumins Tregasio, Val122-->Glu, Bergamo, Asp314-->Gly, and Maddaloni, Val533-->Met. The fourth, albumin Besana Brianza, has the same Asp494-->Asn mutation that introduces a glycosylation site which has been previously reported in a variant from New Zealand, albumin Casebrook. However, in contrast to albumin Casebrook, albumin Besana Brianza is only partially glycosylated and the oligosaccharide is heterogeneous, consisting of a biantennary complex type N-glycan with either two or one sialic acid residue(s) on the antennae. Both albumin Maddaloni and Besana Brianza represent mutations at hypermutable CpG dinucleotide sites; albumin Maddaloni is a mutant that does not involve a charged amino acid.

[1]  M. Galliano,et al.  Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Galliano,et al.  Structural characterization of a chain termination mutant of human serum albumin. , 1986, The Journal of biological chemistry.

[3]  M. Galliano,et al.  Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). , 1993, Biochimica et biophysica acta.

[4]  W. Kuang,et al.  Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. , 1986, The Journal of biological chemistry.

[5]  M. Atassi,et al.  Immunochemistry of serum albumin. X. Five major antigenic sites of human serum albumin are extrapolated from bovine albumin and confirmed by synthetic peptides. , 1980, Molecular immunology.

[6]  A. Dell Preparation and desorption mass spectrometry of permethyl and peracetyl derivatives of oligosaccharides. , 1990, Methods in enzymology.

[7]  M. Nomura,et al.  Structural study of the glycosylated and unglycosylated forms of a genetic variant of human serum albumin (63 Asp-->Asn). , 1995, Biochimica et biophysica acta.

[8]  M. Galliano,et al.  A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. O. Pedersen,et al.  High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin. , 1996, The Biochemical journal.

[10]  M. Galliano,et al.  Mutations in genetic variants of human serum albumin found in Italy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[12]  D. Rochu,et al.  Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. , 1992, Biochimica et biophysica acta.

[13]  M. Galliano,et al.  Analbuminemia: three cases resulting from different point mutations in the albumin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Galliano,et al.  A genetic variant of albumin (albumin Asola; Tyr140-->Cys) with no free -SH group but with an additional disulfide bridge. , 1995, European journal of biochemistry.

[15]  R. Peach,et al.  Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Galliano,et al.  Genetic variants of human serum albumin: molecular defects and biological stability. , 1995, International journal of clinical pharmacology research.

[17]  M. Galliano,et al.  Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Peach,et al.  Characterisation of oligosaccharides from a glycoprotein variant of human serum albumin (albumin Casebrook) using high-performance anion-exchange chromatography and nuclear magnetic resonance spectroscopy. , 1992, Journal of chromatography.

[19]  R. Peach,et al.  Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). , 1991, Biochimica et biophysica acta.

[20]  M. Galliano,et al.  A nucleotide insertion and frameshift cause analbuminemia in an Italian family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Galliano,et al.  The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin. , 1989, The Journal of biological chemistry.

[22]  M. Galliano,et al.  The molecular defect of albumin Tagliacozzo: 313 Lys → Asn , 1986, FEBS letters.

[23]  C. Laurell,et al.  Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Kasturi,et al.  The Amino Acid at the X Position of an Asn-X-Ser Sequon Is an Important Determinant of N-Linked Core-glycosylation Efficiency (*) , 1996, The Journal of Biological Chemistry.

[25]  M. Galliano,et al.  The molecular defect of albumin Castel di Sangro: 536 Lys----Glu. , 1990, Biochimica et biophysica acta.